Concepedia

Ashley Eheim

AE

Statistics

Publications

14

Citations

1.7K

H-Index

13

Active since

2012

Affiliations

Bayer (Germany)(Current)

Broad Institute

Carolinas Medical Center

Harvard University

Dana-Farber Cancer Institute

Ashley Eheim is an author at Bayer (Germany) specializing in medicine, molecular oncology, and oncology.

Publications per year

2012–2022

14

Publications

14

Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia

David B. Sykes, Youmna Kfoury, François Mercier et al. · Cell · 2016 · 488 citations · Full text

, , +14

Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles

John K. Eaton, Laura Furst, Richard A. Ruberto et al. · Nature Chemical Biology · 2020 · 472 citations · Full text

, , +6

The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies

Sven Christian, Claudia Merz, Laura Evans et al. · Leukemia · 2019 · 246 citations · Full text

, , +17

Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance

Maria Quanz, Eckhard Bender, Charlotte Kopitz et al. · Molecular Cancer Therapeutics · 2018 · 109 citations · Full text

, , +16

Identification of Small Molecules that Modulate Mutant p53 Condensation

Clara Lemos, Luise Schulze, Joerg Weiske et al. · iScience · 2020 · 58 citations · Full text

, , +15

1–5 of 14